By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A researcher at the Translational Genomics Research Institute has received a $150,000 grant from the American Cancer Society to identify potential targets of value in fighting acute myeloid leukemia (AML).

James Bogenberger, a researcher in TGen's Leukemia Research Team, will use the three-year grant to fund studies that will identify therapeutic targets that sensitize AML to epigenetic therapies, TGen said on Wednesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.